Choice paralysis. The therapeutic landscape in oncology is vast and everchanging, marked by a dramatic pace of innovation and new approvals.
In this complicated specialty, how can payers and providers keep up to make decisions that maximize life for the patient? Dr. Vinay Prasad, Hematologist-Oncologist; Associate Professor of Medicine, University of California San Francisco; and best-selling author of Malignant: How Bad Policy and Bad Evidence Harm People with Cancer, and Dr. Andrew Hertler, Chief Medical Officer with New Century Health join us to explore this complex topic.
